Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Life Insurance Co ( (HK:2628) ) just unveiled an announcement.
China Life Insurance Company Limited has scheduled a board meeting for 25 March 2026 to review and approve its audited financial results for the year ended 31 December 2025. The board will also consider a proposal for a final dividend and address other corporate matters, a step that will be closely watched by investors for signals on the insurer’s financial performance, capital management, and shareholder returns.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major life insurer incorporated in the People’s Republic of China and listed in Hong Kong. The company operates in the life insurance sector, providing a range of insurance and related financial products to individuals and institutions, with its shares traded under stock code 2628 on the Hong Kong Stock Exchange.
Average Trading Volume: 66,646,867
Technical Sentiment Signal: Buy
Current Market Cap: HK$1218.8B
For a thorough assessment of 2628 stock, go to TipRanks’ Stock Analysis page.

